Bex, Axel <br/><br/>
Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis.  [electronic resource] 

 -  Urologia internationalis  2008 
 - 367-71 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1423-0399 
<br/><br/><label>Standard No.: </label>10.1159/000132693  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma, Renal Cell--drug therapy<br/>Combined Modality Therapy<br/>Confidence Intervals<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Injections, Subcutaneous<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Kidney Neoplasms--drug therapy<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoplasm Invasiveness--pathology<br/>Neoplasm Staging<br/>Nephrectomy--methods<br/>Patient Selection<br/>Probability<br/>Prognosis<br/>Randomized Controlled Trials as Topic<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Risk Assessment<br/>Survival Analysis<br/>Time Factors<br/>Treatment Outcome